Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

• Status: Completed
• Trial end date: 2003-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the efficacy and safety of oral administration of olmesartan medoxomil compared to losartan in subjects with mild to moderate hypertension.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daiichi Sankyo Inc.; Daiichi Sankyo, Inc.
• Collaborator: Daiichi Sankyo Taiwan Ltd.
• Treatments: Angiotensin Receptor Antagonists; Losartan; Olmesartan; Olmesartan Medoxomil

Criteria

Inclusion Criteria:

• Diastolic BP 95 mm Hg - 114 mm Hg inclusive

• No participation in any clinical trial for the last 3 months

Exclusion Criteria:

• Secondary hypertension

• Malignant hypertension

• Severe arterial hypertension

• Significant cardiovascular disease

• History or clinical evidence of cerebrovascular, gastrointestinal, hematological, hepatic disease, myocardial infarction, or severe liver disorder

• Clinical evidence of renal disease, poorly controlled diabetes, known malabsorption syndromes, psychiatric/emotional problems